PT-141 bremelanotide sexual function research centers on melanocortin-4 receptor activation in the hypothalamus. Here is how the neurological arousal pathway differs from vascular mechanisms and what the research timelines show.
PT-141 (bremelanotide) research centers on its role in initiating sexual desire via the central melanocortin system. Unlike vascular-focused compounds, PT-141 targets the neurological circuits that generate the motivational state of arousal.
PT-141 primarily targets the melanocortin-4 receptor (MC4R) in the hypothalamus, particularly the paraventricular nucleus. This activates circuits responsible for sexual motivation rather than just the reflexive vascular response. Research published in the International Journal of Impotence Research established this central neurological mechanism as distinct from PDE5 inhibitors.
In female sexual dysfunction research, PT-141 addresses Hypoactive Sexual Desire Disorder (HSDD) where the primary impairment is desire. While vascular compounds fail when desire is lacking, PT-141's central mechanism engages the motivational and desire circuitry directly.
Kinetics in research models show behavioral effects appearing 1-2 hours after subcutaneous administration and persisting for 6-12 hours, suggesting sustained neural circuit activation. Beyond Health Lab supplies PT-141 10mg at ≥99% verified purity.
Join 10,000+ researchers. Get your discount code, early access to new compounds, and protocol insights.
No spam, ever. Unsubscribe anytime.
Check your inbox for your discount code.
Here's a preview:
Valid on all products · Single use
